Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Kyle Robert A, Gertz. Morie A.
Primary systemic amiloidosis: clinical and laboratory features in 474 cases.
Semin Hematol, 32 (1995), pp. 45-49
[2.]
A. Morie, Gertz, A. Robert.
Hepatic amyloidosis (Primary AL. immunoglobulin light chain): the natural history in 80 patients.
Am J Med, 85 (1998), pp. 73-80
[3.]
J.D. Gillmore, L.B. Lovat, P.N. Hawkins.
Amyloidosis and the liver.
J Hepatol, 30 (1999), pp. 17-33
[4.]
L.B. Lovat, M.R. Persey, S. Madhoo, M.B. Pepys, P.N. Hawkins.
The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
Gut, 42 (1998), pp. 727-734
[5.]
M. Iwai, Y. Ishii, T. Mori, Y. Harada, Y. Kitagawa, M. Kashiwadani, et al.
Cholestatic jaundice in two patients with primary amyloidosis.
J Clin Gastroenterol, 28 (1999), pp. 162-166
[6.]
D.C. Rockey, N.C. Durhan.
Striking Cholestatic Liver Disease: A distinct manifestation of Advanced Primary Amyloidosis.
South Med J, 92 (1999), pp. 236-241
[7.]
A. Segev, Y. Manor, Bernhein, A. Mekori.
Light Chain myeloma presenting as severe obstructive jaundice due to hepatic amyloidosis.
Eur J Haematol, 63 (1999), pp. 364-365
[8.]
D.R. Booth, S.Y. Tan, S.E. Booth, G.A. Tennent, W.L. Hutchimson, J.J. Hsuan, et al.
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.
J Clin Invest, 97 (1996), pp. 2714-2721
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
